Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NIH offers new patented therapy for primary brain tumors for licensing

Dec. 18, 1998

Novel orally active tumor angiogenesis inhibitors licensed by Cell Therapeutics

Dec. 18, 1998

Pivotal clinical trials begin for Epic's sustained-release LHRH analogue

Dec. 18, 1998

British Biotech discontinues marimastat monotherapy study in ovarian cancer

Dec. 17, 1998

Liposome Co. files for approval of Evacet in U.S.

Dec. 17, 1998

Orphan Medical files NDS for Busulfex Injection in Canada

Dec. 17, 1998

Merck KGaA prefers alliances to mergers; signs new deal with ImClone Systems

Dec. 16, 1998

Phase II trials of Xenova's P-gp pump inhibitor planned in U.S. and U.K.

Dec. 16, 1998

Clinical studies support excellent safety and efficacy of Busulfex

Dec. 15, 1998

New antitumor compounds presented by Kyorin

Dec. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...